# Autologous Transplantation for Chronic Myelogenous Leukemia

> **NCT01003054** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 24 (actual)

## Conditions studied

- Chronic Myelogenous Leukemia

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Cyclophosphamide
- **DRUG:** Imatinib Mesylate
- **PROCEDURE:** Autologous Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT01003054
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2007-12
- **Final completion:** 2009-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01003054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01003054, "Autologous Transplantation for Chronic Myelogenous Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01003054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*